Aethlon Medical AEMD
NASDAQ AEMD
$6.45 -0.18 (-2.71%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aethlon Medical (AEMD) Gains from Sales and Divestitures (2024)

Updated

Aethlon Medical's Gains from Sales and Divestitures came in at -$24,406 for fiscal Q4 2024 (quarter ended Mar 31, 2024).

Analysis

Aethlon Medical (AEMD) Gains from Sales and Divestitures (2024) Analysis & Trends

For FY2024 (ended Mar 31, 2024), Aethlon Medical's Gains from Sales and Divestitures was -$21,135.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Aethlon Medical 2.48 Mn 2.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -24,406.00
API Access

Aethlon Medical Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=AEMD&period=max&api_key=YOUR_API_KEY